Health
Early-stage trial data on AstraZeneca COVID-19 vaccine due Monday – Lancet – Reuters UK
Early-stage human trial data on a vaccine being developed by AstraZeneca and Oxford University will be published on July 20, The Lancet medical journal said on Wednesday.
LONDON (Reuters) – Early-stage human trial data on a vaccine being developed by AstraZeneca and Oxford University will be published on July 20, The Lancet medical journal said on Wednesday.
The vaccine candidate is already in large-scale Phase III human trials to assess whether it can protect against COVID-19, but its developers have yet to report Phase I results which would show whether it is safe and whether or not it induces an immune response.
“We expect this paper, which is undergoing f…
-
General23 hours agoInjured former Greens candidate Hannah Thomas charged with hindering or resisting police at pro-Palestinian protest
-
General22 hours agoTony Burke’s detention inaction | The Spectator Australia
-
General13 hours agoMelbourne lawyer fled Australia with $1.2m after filing for bankruptcy, court case alleges
-
General21 hours agoGrattan Institute pitches blueprint to ‘save’ NDIS as foundational supports rollout stalls